Smart Pills Patient Monitoring Market Analysis by Target Area (Esophagus, Stomach, Small Intestine, and Large Intestine); by Application (Capsule Endoscopy, Patient Monitoring, and Drug Delivery); by Disease Indication (Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes, Neurological Disorders, Crohn's Disease, Occult GI Bleeding, and Others); and by End-User (Hospitals, Specialty Clinics, and Others) â€“ Global Supply & Demand Analysis & Opportunity Outlook 2023-2035

Request Free Sample Copy

Report ID: 3864
Published Date: Mar 01, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Smart Pills Patient Monitoring Landscape

AbbVie Inc

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

Browse Key Market Insights with Data Illustration:

Smart Pills Patient Monitoring Market Size & Share, Forecast Report 2035

In the News

AbbVie Inc., announced a strategic collaboration with HotSpot Therapeutics Inc. to expand its immunology pipeline. This collaboration is estimated to lead to the development of the first and only small molecule inhibitor of IRF5 (interferon regulatory factor 5) intended for the treatment of autoimmune diseases using HotSpot's Smart Allostery drug discovery platform.
etectRx, to partner up with Pear Therapeutics, to make wireless sensors embedded in medications. Through the collaboration, both companies intend to develop further products combining medication adherence data with digital therapeutics.

Frequently Asked Questions (FAQ)

Increasing ratio of various types of chronic disorders, rising prevalence of gastrointestinal reflux disease (GERD), and worldwide increase in neurological disorders are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 16% over the forecast period, i.e., 2023-2035.

High cost of smart pills, stringent government regulations about the use of smart pills, and technical incompetence of smart pills in some disorders are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Medtronic plc, AbbVie Inc., Novartis AG, CapsoVision, Inc., Medimetrics, SA de CV, TauRx Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd., FUJIFILM Holdings Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by target area, application, disease indication, end-user, and by region.

The capsule endoscopy segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Smart Pills Patient Monitoring Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the smart pills patient monitoring market?

What would be the CAGR of smart pills patient monitoring market over the forecast period?

What are the challenges affecting the smart pills patient monitoring market growth?

Which region will provide more business opportunities for growth of smart pills patient monitoring market in future?

Who are the major players dominating the smart pills patient monitoring market?

How are the company profiles selected?

What are the segments in the smart pills patient monitoring market?

Which segment captures the largest market size in end-user segment in the smart pills patient monitoring market?